Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness

NCT: NCT05617794 · ACTIVE_NOT_RECRUITING

NCT IDNCT05617794
StatusACTIVE_NOT_RECRUITING
Start Date2023-01-18
Completion2026-12-31

Brief Summary

The objective of the study is to measure the effect of Diffusion Optics Technology (DOT) spectacle lenses on the choroidal thickness and choroidal vascularity index compared to control lenses.

Frequently Asked Questions

What is Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness?

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness is a clinical trial registered under NCT05617794. Current status: ACTIVE_NOT_RECRUITING.

What is the status of NCT05617794?

The current status of NCT05617794 (Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness) is: ACTIVE_NOT_RECRUITING.

When did Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness start?

Effect of Diffusion Optics Technology (DOT) Spectacle Lenses on Choroidal Thickness started on 2023-01-18.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑